Literature DB >> 1479298

Experimental and clinical gnotobiotics: influence of the microflora on graft-versus-host disease after allogeneic bone marrow transplantation.

P J Heidt1, J M Vossen.   

Abstract

One of the major complications of allogeneic bone marrow transplantation (BMT) is graft-versus-host disease (GvHD), which is caused by donor type lymphocytes which react against the recipient's tissues. An important factor which influences GvHD is the recipient's gastrointestinal microflora. This was originally observed in gnotobiotic mice. Infusion of 10(7) H-2 incompatible bone marrow cells into lethally irradiated (9.0 Gy X-rays) conventional mice results in a late onset type GvHD which causes the death of the majority of the recipients during the first two months after BMT. This mortality can be completely prevented if the recipients are germfree mice, or when they are conventional animals which have been subjected to complete or selective gastrointestinal decontamination (GID). In a mouse model, the mechanism responsible for the influence of the microflora on GvHD after allogeneic BMT was investigated. These studies indicate that GvHD can be induced by activated T-lymphocytes from donor origin reacting against bacterial antigens which might be cross-reactive with the recipient's epithelial tissue antigens. Activation of these T-lymphocytes is confined to antigens of certain bacterial species of the recipient which are not present in the indigenous microflora of the donor mice. These bacteria most likely belong to the anaerobic flora of the recipient. The latter hypothesis is strongly supported by the observation in human patients that, in contrast to complete GID, selective decontamination of the gastrointestinal tract did not have any beneficial effect on moderately severe to severe GvHD after transplantation with MHC-matched sibling donor bone marrow grafts.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1479298

Source DB:  PubMed          Journal:  J Med        ISSN: 0025-7850


  15 in total

1.  Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli.

Authors:  M M Heimesaat; A Fischer; H-K Jahn; J Niebergall; M Freudenberg; M Blaut; O Liesenfeld; R R Schumann; U B Göbel; S Bereswill
Journal:  Gut       Date:  2007-01-25       Impact factor: 23.059

Review 2.  Oral graft-versus-host disease.

Authors:  M M Imanguli; I Alevizos; R Brown; S Z Pavletic; J C Atkinson
Journal:  Oral Dis       Date:  2008-07       Impact factor: 3.511

3.  Is human cell therapy research caught in a mousetrap?

Authors:  A John Barrett; J Joseph Melenhorst
Journal:  Mol Ther       Date:  2011-02       Impact factor: 11.454

4.  LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation.

Authors:  K R Cooke; A Gerbitz; J M Crawford; T Teshima; G R Hill; A Tesolin; D P Rossignol; J L Ferrara
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

5.  The Human Microbiome and the Immune System: An Ever Evolving Understanding.

Authors:  Vanessa Rivera-Amill
Journal:  J Clin Cell Immunol       Date:  2014-11-05

Review 6.  The gut microbiota and graft-versus-host disease.

Authors:  David N Fredricks
Journal:  J Clin Invest       Date:  2019-05-01       Impact factor: 14.808

7.  Allogeneic hematopoietic cell transplantation following minimal intensity conditioning: predicting acute graft-versus-host disease and graft-versus-tumor effects.

Authors:  Rainer Storb; Boglarka Gyurkocza; Barry E Storer; David G Maloney; Mohamed L Sorror; Marco Mielcarek; Paul J Martin; Brenda M Sandmaier
Journal:  Biol Blood Marrow Transplant       Date:  2013-02-14       Impact factor: 5.742

Review 8.  Intestinal permeability defects: is it time to treat?

Authors:  Matthew A Odenwald; Jerrold R Turner
Journal:  Clin Gastroenterol Hepatol       Date:  2013-07-12       Impact factor: 11.382

9.  Recipient NK cell inactivation and intestinal barrier loss are required for MHC-matched graft-versus-host disease.

Authors:  Sam C Nalle; H Aimee Kwak; Karen L Edelblum; Nora E Joseph; Gurminder Singh; Galina F Khramtsova; Eric D Mortenson; Peter A Savage; Jerrold R Turner
Journal:  Sci Transl Med       Date:  2014-07-02       Impact factor: 17.956

Review 10.  Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology.

Authors:  P G Falk; L V Hooper; T Midtvedt; J I Gordon
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.